Intermedi SRL
8.6 FTEThe score of Intermedi shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -9 % Total assets -3 % Headcount (avg FTE) -13 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Intermedi's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 26 Jun 2026
- Year ended 31 Dec 2024filed on 13 Jun 2025
- Year ended 31 Dec 2023filed on 19 Jul 2024
- Year ended 31 Dec 2022filed on 30 Jun 2023
- Year ended 31 Dec 2021filed on 28 Jul 2022
Intermedi's financial analysis
- Solvency78.5%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Intermedi
Intermedi's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0424.574.344
- VAT number
- BE0424574344
- Peppol
- Registered · 0208:0424574344 · as of 05 Nov 2026
- Legal form
- SRL
- Incorporated
- 27 Sep 1983
- Registered office
- 9031 Ghent
- Size
- Micro · 8.6 FTE
- Latest accounts
- 2025 · filed on 26 Jun 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Intermedi (SRL) has been based in Ghent since 1983, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 21,327 € and equity of 910,884 €; its revenue is not published. With 8.6 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 78.5%, above the median of its sector (46.0%).
Companies similar to Intermedi
Companies in the same business, of comparable size and area, outside its group.
- Echomedic Wholesale of pharmaceutical and medical goods Deinze · balance sheet €1.36m
- D.I. Wholesale of pharmaceutical and medical goods Anzegem · balance sheet €3.69m
- W M Hopital (B) Wholesale of pharmaceutical and medical goods Mont-de-l'Enclus · balance sheet 683,247 €
- Pharmentum Manufacture of pharmaceutical preparations Kontich · balance sheet €1.94m
- ECO.Pharma.Supply Wholesale of pharmaceutical and medical goods Estaimpuis · balance sheet €2.01m
- Primrose Farma Belgica Wholesale of pharmaceutical and medical goods Torhout · balance sheet €1.23m
- Hasa Optix Wholesale of pharmaceutical and medical goods Ixelles · balance sheet €1.29m
- Dentalbiolux International Wholesale of pharmaceutical and medical goods Schaerbeek · balance sheet €1.37m
Frequently asked questions about Intermedi
What is the revenue of Intermedi?
Intermedi files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Intermedi?
In Belgium, the VAT number is the company number prefixed with BE: BE0424574344 for Intermedi, if the company is VAT-registered. Its company number (CBE) is 0424.574.344.
Where is the registered office of Intermedi?
According to the CBE register, the registered office of Intermedi is in 9031 Ghent.
What is the equity of Intermedi?
At the close of the 2025 financial year, the equity of Intermedi amounts to 910,884 €, a solvency of 78.5% of total assets.
How many people work at Intermedi?
8.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Intermedi?
The register lists 2 active mandates at Intermedi. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Intermedi
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →